Cinacalcet HCl controls secondary hyperparathyroidism (HPT) in dialysis patients regardless of disease severity.

被引：0
|
作者：
Quarles, LD
Zeig, S
Spiegel, DM
Silver, MR
Vokes, TJ
Torregrosa, JV
Reichel, H
Horl, WH
Zani, V
Klassen, PS
Olson, KA
Turner, SA
Sprague, SM
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Pines Clin Res, Pembroke Pines, FL USA
[3] Univ Colorado, HSC, Denver, CO 80202 USA
[4] MHMC, CWRU, Cleveland, OH USA
[5] Univ Chicago Hosp, Chicago, IL 60637 USA
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Nephrol Ctr, Villingen Schwenningen, Germany
[8] Univ Vienna, Innere Med Klin 3, Vienna, Austria
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
[10] Evanston Hosp Corp, Evanston, IL 60201 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：463A / 463A
页数：1
相关论文
共 50 条
  • [21] Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl
    Eriguchi, Rieko
    Umakoshi, Junko
    Tominaga, Yoshihiro
    Sato, Yuzuru
    CLINICAL KIDNEY JOURNAL, 2008, 1 (04): : 218 - 220
  • [22] Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease
    Quarles, LD
    KIDNEY INTERNATIONAL, 2005, 68 : S24 - S28
  • [23] EFFICACY OF CINACALCET THERAPY FOR DIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM: A META-ANALYSIS
    Wang, Zhe
    Jiang, Aili
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [24] Effects of cinacalcet on gastrointestinal hormone release in patients with secondary hyperparathyroidism undergoing dialysis
    Diez, Juan J.
    Miguel, Jose Luis
    Codoceo, Rosa
    Iglesias, Pedro
    Bajo, M. Auxiliadora
    Sanchez, Carmen
    del Peso, Gloria
    Gil, Fernando
    Martinez-Ara, Jorge
    Gancedo, Pilar Gonzalez
    Selgas, Rafael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (04) : 1387 - 1395
  • [25] Evolution of Secondary Hyperparathyroidism After Kidney Transplantation in Patients Receiving Cinacalcet on Dialysis
    Torregrosa, J. -V.
    Bergua, C.
    Martinez de Osaba, M. J.
    Oppenheimer, F.
    Campistol, J. M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2396 - 2398
  • [26] Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis
    Charytan, C
    Coburn, JW
    Chonchol, M
    Herman, J
    Lien, YH
    Liu, W
    Klassen, PS
    McCary, LC
    Pichette, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) : 58 - 67
  • [27] Effect of Cinacalcet HCl and Maxacalcitol combination therapy for secondary hyperparathyroidism in chronic hemodialysis patients
    Saito, K.
    Kimura, Y.
    Sato, H.
    Ono, M.
    Ohta, Y.
    Ogawa, H.
    BONE, 2009, 44 (02) : S361 - S361
  • [28] Cinacalcet HCL for Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients: A Single Centre Experience
    Qaisar, Mansoor Abbas
    Nadeem, Muhammad
    Chattah, Fateh Sher
    Roop, Zarmina
    Hashir, Muhammad Mujtaba
    Iqbal, Bushra
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (04): : 995 - 997
  • [29] Cinacalcet for secondary hyperparathyroidism in ESRD patients
    Kirby R.
    Nature Clinical Practice Nephrology, 2006, 2 (1): : 8 - 9
  • [30] Cinacalcet (Mimpara®/Sensipar®) effectively reduces intact parathyroid hormone (iPTH) and serum calcium (Ca) regardless of serum calcium level in patients with secondary hyperparathyroidism (HPT)
    De Francisco, A
    Evenepoel, P
    Brink, HS
    Mellotte, G
    Barata, JD
    Zani, V
    Hutton, S
    Klassen, P
    Ritz, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V197 - V198
12345